The cheap-forever argument just hit a capital plan. The real question is whether token deflation kills application...
The Phase 3 win validated the platform. Now the harder work begins: manufacturing every dose from scratch.
Freeport LNG returns in late August as EU storage lags seasonal norms.
The Ultra I&C deal closed Monday. Whether it lifts FY27 depends on how fast OT cyber spending...
Thursday’s FDA decision on bictegravir plus lenacapavir will test how much of Gilead’s future depends on a...
Three power-infrastructure bets in one month suggest a supply-chain strategy that many investors are treating as philanthropy.
Healthcare has outrun SOXX since June. The flows have barely started.
Three separate catalysts converged this week to produce Bitcoin's strongest weekly gain since March 2023. Only one...
Tariff refunds made the quarter. The Q3 guide reveals the margin question.
T-bills still pay. Long Treasuries are bleeding. The $7.93 trillion parked in money markets is sitting on...
